Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...